Abstract
The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) eventually leads to rapid emergence of drug-resistant viruses and severe side effect. Therefore, it is imperative to seek the additional NNRTIs with potent and broad spectrum anti-mutant activities, and excellent pharmacokinetic profiles. The discovery of etravirine, rilpivirine and other successful examples has influenced the NNRTIs design strategy profoundly. Sustained efforts in this area have led to the identification of many promising NNRTIs hits, leads and candidates for the last few years. Hence, this review aims to highlight recent prominent advances in this field as well as contributions from our laboratory toward the discovery of novel potent NNRTIs from 2009 to 2013 (by May).
Keywords: AIDS, drug design, drug resistance, HIV, inhibitor, NNRTIs, RT.
Current Medicinal Chemistry
Title:Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms (Part II): 2009-2013 Update#
Volume: 21 Issue: 3
Author(s): Yu’ning Song, Zengjun Fang, Peng Zhan and Xinyong Liu
Affiliation:
Keywords: AIDS, drug design, drug resistance, HIV, inhibitor, NNRTIs, RT.
Abstract: The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) eventually leads to rapid emergence of drug-resistant viruses and severe side effect. Therefore, it is imperative to seek the additional NNRTIs with potent and broad spectrum anti-mutant activities, and excellent pharmacokinetic profiles. The discovery of etravirine, rilpivirine and other successful examples has influenced the NNRTIs design strategy profoundly. Sustained efforts in this area have led to the identification of many promising NNRTIs hits, leads and candidates for the last few years. Hence, this review aims to highlight recent prominent advances in this field as well as contributions from our laboratory toward the discovery of novel potent NNRTIs from 2009 to 2013 (by May).
Export Options
About this article
Cite this article as:
Song Yu’ning, Fang Zengjun, Zhan Peng and Liu Xinyong, Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms (Part II): 2009-2013 Update#, Current Medicinal Chemistry 2014; 21 (3) . https://dx.doi.org/10.2174/09298673113206660298
DOI https://dx.doi.org/10.2174/09298673113206660298 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Spirolactones: Recent Advances in Natural Products, Bioactive Compounds and Synthetic Strategies
Current Medicinal Chemistry State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging Potential Applications of Hydrogen Sulfide-Induced Suspended Animation
Current Medicinal Chemistry Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry A Short Exploration of Selected Sensitive CYP3A4 Substrates (Probe Drug)
Drug Metabolism Letters Artificial Intelligence in Accelerating Drug Discovery and Development
Recent Patents on Biotechnology Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Kinetic, Thermodynamic, and Mechanistic Aspects of Oxidative Addition Reactions of RE-ER (E = S, Se, Te) and Transition Metal Complexes
Current Organic Chemistry Stem Cell Therapy: A Promising Approach in Treatment of COVID-19
Current Stem Cell Research & Therapy Mechanisms of Plant Defense Under Pathogen Stress: A Review
Current Protein & Peptide Science Homocysteine and Cerebral Stroke in Developing Countries
Current Medicinal Chemistry The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Current Pharmaceutical Design Practical Review of Mechanical Ventilation in Adults and Children in the Operating Room and Emergency Department
Reviews on Recent Clinical Trials Determination of Fluoride in Mouthwash Using Flow-injection Analysis with Spectrophotometric Detection
Current Pharmaceutical Analysis Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic
Reviews on Recent Clinical Trials Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Current Pharmaceutical Design Malaria in Children - Prevention and Management
Infectious Disorders - Drug Targets Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Current Molecular Pharmacology 2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors
Medicinal Chemistry The Type III Secretion System as a Source of Novel Antibacterial Drug Targets
Current Drug Targets